Simedis - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | 46,919 | 8,855 | 60,740 | - | 32,344 | 36,747 |
| Profit before tax | - | - | - | - | 7,232 | 2,743 |
| Net profit | 13,570 | 6,116 | 25,427 | 0 | 6,832 | 2,577 |
| Equity | 6,797 | 6,116 | 25,427 | - | 7,389 | 8,604 |
| Liabilities | 2,475 | 0 | 0 | 0 | 8,935 | 7,813 |
| Non-current assets | 124 | 887 | 0 | 0 | 10,108 | 8,265 |
| Current assets | 6,459 | 5,229 | 0 | 0 | 6,216 | 8,152 |
| Total assets | 6,583 | 6,116 | 0 | 0 | 16,324 | 16,417 |
|
Taxes paid
|
||||||
| STI taxes | - | - | - | 116 | - | 346 |
|
Financial indicators
|
||||||
| Revenue change y/y | +107.4% | - | +585.9% | - | - | +13.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 206.1% | 100.0% | - | - | 41.9% | 15.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 199.6% | 100.0% | 100.0% | - | 92.5% | 30.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 28.9% | 69.1% | 41.9% | - | 21.1% | 7.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | 22.4% | 7.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.4 | - | - | - | 1.2 | 0.9 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 13,685 | 8,855 | 38,363 | - | 24,259 | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Simedis - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-06-18 | 2024-07-15 | 0.34 |
| 2024-05-16 | 2024-06-13 | 0.65 |
| 2024-04-23 | 2024-05-15 | 0.75 |
| 2024-04-16 | 2024-04-16 | 122.66 |
| 2024-01-16 | 2024-01-21 | 561.54 |
Simedis - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-03-15 | 2025-03-17 | 1134.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Simedis, MB (code 304230037) is a Small partnership engaged in new construction. In the latest financial year, 2025, the company generated revenue of €36.7K, up 13.6% from €32.3K in 2024. Net profit was €2.6K in 2025, compared with €6.8K a year earlier, and the net profit margin decreased to 7.0% from 21.1%. The two-year trend shows revenue growth alongside a notable decline in profitability. At the end of 2025, total assets stood at €16.4K, with equity of €8.6K and liabilities of €7.8K. Long-term assets were €8.3K and short-term assets €8.2K, indicating a balanced asset structure. Latest-year ratios show ROE of 29.9%, ROA of 15.7%, debt-to-equity of 0.91 and asset turnover of 2.24x. Overall, the company remained profitable in 2025, with a stronger revenue base but lower earnings efficiency than in 2024.